However, in the advanced stages, tumor cells secrete other anti-inflammatory cytokines and chemical factors, such as CCL-2 and epidermal growth factor (EGF), leading to the recruitment and conversion of TAMs from the M1 to the M2 phenotype. This evidence concerns the gene EGF and neoplasm.